Castle Biosciences (CSTL) Change in Acquisitions & Divestments (2023 - 2026)

Castle Biosciences has disclosed Change in Acquisitions & Divestments across 4 years of filings, most recently posting $2.7 million for Q1 2026.

• Change in Acquisitions & Divestments for Q1 2026 came in at $2.7 million, down 92.61% year-over-year; the trailing twelve-month figure through Mar 2026 was $155.6 million (up 1219.29% YoY), and the FY2025 annual result was $189.2 million, changed N/A from the prior year.
• Change in Acquisitions & Divestments came in at $2.7 million for Q1 2026 at Castle Biosciences, down from $54.0 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $54.9 million in Q3 2025 to a low of -$123.2 million in Q4 2024.
• The 4-year median for Change in Acquisitions & Divestments is $44.0 million (2025), against an average of $29.1 million.
• Across the five-year window, Change in Acquisitions & Divestments slumped 354.12% in 2024 and surged 143.81% in 2025, its largest moves.
• Castle Biosciences' Change in Acquisitions & Divestments stood at $48.5 million in 2023, then plunged by 354.12% to -$123.2 million in 2024, then surged by 143.81% to $54.0 million in 2025, then plunged by 95.04% to $2.7 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $2.7 million (Q1 2026), $54.0 million (Q4 2025), and $54.9 million (Q3 2025), per Business Quant data.